We are here to break the isolation so often felt by those with these rare diseases, and we would be delighted to welcome you into our 'family'.
The aim of our website is to direct you as quickly as possible to our support services and to information you can trust on multiple endocrine neoplasia (MEN) types 1, 2, and 3, medullary thyroid cancer (MTC), familial medullary thyroid cancer (FMTC), adrenal gland tumours (phaeochromocytomas), parathyroid hyperplasia, paragangliomas, familial isolated pituitary adenoma (FIPA) and succinate dehydrogenase (SDH) disorders.
On Saturday 6th May in Central Manchester, we held our 2017 Annual Patient Information Day.
All those affected by multiple endocrine neoplasia (MEN), succinate dehydrogenase syndromes (SDHx) and adrenocortical cancer (ACC) were invited to this popular day-long event to listen to some fascinating talks and participate in some useful workshops. Sessions included those on Transition, Understanding Research Articles, Using Social Media for Support, as well as patient experiences.
The filmed presentations are now available to view on our YouTube Channel (AMEND3). Click here to view the playlist.
We are already taking bookings for our 2018 Information Day on 12th May in London. Click here for more information and to book!
We are delighted to announce that Professor Maralyn Druce has joined AMEND's Medical Advisory Team.
Professor Druce, a consultant endocrinologist from St Bartholomew's Hospital in London has special expertise in medical education and we know that she will be a great addition to our wonderful team.